Clinical Trial Update: Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing budesonide, mesalazine, and budesonide/mesalazine suppository therapy in acute ulcerative proctitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis
• Ulcerative Proctitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• Mesalazine (mesalazine)
• budesonide/mesalazine suppository (budesonide/mesalazine suppository)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Proctitis | Phase 2 | Status: COMPLETED